Harrow (HROW) Capital Expenditures (2012 - 2026)
Harrow (HROW) posted quarterly Capital Expenditures of $194000.0 for Q1 2026, up 14.12% year-over-year from $170000.0 in Q1 2025, and down 43.11% quarter-over-quarter from $341000.0 in Q4 2025.
Harrow (HROW) Capital Expenditures (2012 - 2026) Analysis & Trends
Harrow's Capital Expenditures history runs 15 years deep, the most recent figure standing at $194000.0 for Q1 2026.
- In Q1 2026, Capital Expenditures rose 14.12% year-over-year to $194000.0; the TTM figure through Mar 2026 stood at $911000.0 (down 45.64% YoY), while the FY2025 annual figure was $887000.0, down 44.39% from the prior year.
- Capital Expenditures for Q1 2026 stood at $194000.0, down from $341000.0 in the prior quarter.
- The five-year high for Capital Expenditures was $1.4 million in Q4 2024, with the low at -$381000.0 in Q2 2023.
- The 5-year median for Capital Expenditures is $260000.0 (2022), against an average of $396058.8.
- The sharpest annual moves came in 2023 and 2024: Capital Expenditures slumped 246.54% in 2023, then jumped 630.93% in 2024.
- Harrow's Capital Expenditures stood at $878000.0 in 2022, then slumped by 77.9% to $194000.0 in 2023, then surged by 630.93% to $1.4 million in 2024, then sank by 75.95% to $341000.0 in 2025, then slumped by 43.11% to $194000.0 in 2026.
- Business Quant data shows HROW's Capital Expenditures at $194000.0 in Q1 2026, $341000.0 in Q4 2025, and $416000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 104.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 117.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -337.60 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 108.00 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 52.80 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 7.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 33.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Harrow | 1.56 Bn | 1.47 Bn | 50.36 Mn | 491,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 491,000.00 |
| Jun 30, 2026 | 491,000.00 |
| Mar 31, 2026 | 194,000.00 |
| Mar 31, 2026 | 194,000.00 |
| Dec 31, 2025 | 341,000.00 |
| Dec 31, 2025 | 341,000.00 |
| Sep 30, 2025 | 416,000.00 |
| Sep 30, 2025 | 416,000.00 |
| Jun 30, 2025 | -40,000.00 |
| Jun 30, 2025 | -40,000.00 |
| Mar 31, 2025 | 170,000.00 |
| Mar 31, 2025 | 170,000.00 |
| Dec 31, 2024 | 1.42 Mn |
| Dec 31, 2024 | 1.42 Mn |
| Sep 30, 2024 | 133,000.00 |
| Sep 30, 2024 | 133,000.00 |
| Jun 30, 2024 | -45,000.00 |
| Jun 30, 2024 | -45,000.00 |
| Mar 31, 2024 | 89,000.00 |
| Mar 31, 2024 | 89,000.00 |